TORONTO, ON / ACCESSWIRE / March 29, 2022 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced the appointment of Jennifer M. Chao to the...
Bedford Group Transearch Life Sciences practice congratulates Edesa Biotech on the Board Appointment of Jennifer Chao
read more




